- Home
- VOR vs ATRA Comparison
VOR vs ATRA Comparison
Compare VOR & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | ATRA |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 934.7M | 38.9M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VOR | ATRA |
|---|---|---|
| Price | $14.90 | $9.39 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 10 | 2 |
| Target Price | ★ $45.33 | $5.00 |
| AVG Volume (30 Days) | 818.8K | ★ 3.0M |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.17 | $3.92 |
| 52 Week High | $49.95 | $19.15 |
Technical Indicators
Market Signals| Indicator | VOR | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 64.28 |
| Support Level | $11.74 | $4.35 |
| Resistance Level | $16.87 | $12.91 |
| Average True Range (ATR) | 1.00 | 1.33 |
| MACD | -0.09 | 0.15 |
| Stochastic Oscillator | 27.06 | 60.55 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).